Table 4.
The proportion of patients who were able to discontinue the medication.
| Anticonvulsant | Analgesics | |||||
|---|---|---|---|---|---|---|
| TFEI Group, n (%) | ESPB Group, n (%) | p-Value | TFEI Group, n (%) | ESPB Group, n (%) | p-Value | |
| 1 week | 1/31 (3.12%) | 0/21 (0.00%) | 0.413 | 1/31 (3.12%) | 0/21 (0.00%) | 0.413 | 
| 1 month | 3/29 (9.37%) | 6/15 (28.57%) | 0.069 | 6/26 (18.75%) | 8/13 (38.09%) | 0.202 | 
| 2 months | 25/7 (78.13%) | 19/2 (90.48%) | 0.126 | 26/6 (81.25%) | 20/1 (95.24%) | 0.223 | 
| 3 months | 29/3 (90.63%) | 20/1 (95.24%) | 0.644 | 29/3 (90.63%) | 21/0 (100.00%) | 0.149 | 
TFEI: Transforaminal epidural injection. ESPB: Erector spinae plane block.